Loading...

Bayer AG

BAYN.DEXETRA
Healthcare
Drug Manufacturers - General
40.74
0.13(0.32%)
German Market opens in 7h 48m

Bayer AG (BAYN.DE) Stock Competitors & Peer Comparison

See (BAYN.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BAYN.DE€40.74-0.12%39.9B-11.04-€3.68+0.27%
LLY.DE€771.00-3.14%749.1B40.31€19.67+0.68%
JNJ.DE€201.50-0.07%491.6B21.58€9.46+2.18%
4AB.DE€175.40+0.72%312.5B87.45€2.02+3.24%
6MK.DE€99.45-2.58%251.9B16.33€6.24+2.79%
ZEG.DE€160.70+0.59%249.2B28.75€5.59+1.69%
AMG.DE€293.20-1.23%160.1B24.31€12.22+2.78%
GIS.DE€117.60+0.29%147.8B20.53€5.80+2.30%
PFE.DE€22.96+0.15%131.5B19.93€1.16+6.35%
PFE.F€23.12+0.57%131.5B19.93€1.16+6.36%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BAYN.DE vs LLY.DE Comparison April 2026

BAYN.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYN.DE stands at 39.9B. In comparison, LLY.DE has a market cap of 749.1B. Regarding current trading prices, BAYN.DE is priced at €40.74, while LLY.DE trades at €771.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYN.DE currently has a P/E ratio of -11.04, whereas LLY.DE's P/E ratio is 40.31. In terms of profitability, BAYN.DE's ROE is -0.12%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, BAYN.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for BAYN.DE.Check LLY.DE's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions